Medicinal cannabis group Cilo Cybin will join the JSE’s AltX market as a special purpose acquisition vehicle (SPAC) on 25 June 2024. This is according to a statement released yesterday by the JSE’s SENS service. This is an excerpt from a circular to cannabis stakeholders from founder Gabriel Theron who says the funds will be invested in the group’s Midrand facility.
Gabriel Theron, founder/CEO Cilo Cybin
13 June 2024 at 12:00:00
Update on Cilo Cybin Pharmaceutical -(Target Acquisition)
Allow me to share an update on Cilo Cybin Pharmaceutical, it is still the only fully vertically integrated licenced medical cannabis company in South Africa. Since our last communication, Cilo Cybin Pharmaceutical has continued to soar in the contract manufacturing sector globally, earning respect for its exceptional quality, high standards, and ethical practices.
Our expansion efforts are well underway, significantly increasing our processing capacity. This will position us as one of the largest GMP Medicinal Cannabis manufacturing facilities on the continent, ready to meet growing demand and serve our clients with unparalleled excellence. And here's the best part: Cilo Cybin Pharmaceutical is now profitable. This achievement highlights our successful strategies and commitment to sustainable growth and innovation.
Industry Milestones and Future Prospects
The recent passing of the Cannabis Bill two weeks ago on 28th May 2024 marks a significant leap forward for our industry. This legislation not only enhances our position but also opens new avenues for growth and innovation in the medicinal cannabis and biotech sectors.
Cilo Cybin Holdings find ourselves uniquely positioned as we will be the only tradeable listed company on the JSE with a focus on the cannabis industry. Yes, you read that right!
We are also thrilled to inform you that our partner, Alps Global Holdings Limited (ALPS), and their impending listing on Nasdaq set for later this year is progressing positively. This development further solidifies our strategic position and opens up more opportunities for collaboration and growth.
Cilo Cybin Holdings Ltd. was founded to explore and invest in the Biotech, Biohacking, and Pharmaceutical sectors. Our mission is to leverage Artificial Intelligence and medical expertise to develop holistic and individualized health solutions. Our partnership with ALPS underscores our commitment to cutting-edge technology and personalized medicine.
We have laid a solid foundation as the market continues to open up. While others are still setting up, we've already waded through the murky waters since our inception and emerged stronger. Our listing, partnerships and profitability signify that we are well-positioned and ready to seize new opportunities and lead the way in this exciting space.
Read all Cannabiz Africa's coverage of Cilo Cybin here
#
Cannabiz Africa Weekly Newsline
The Business Of Cannabis
Free every Thursday.